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Abstract Sodium buffer capacity of vascular endothelium
depends on an endothelial glycocalyx rich in negatively
charged heparan sulfate. It has been shown recently that
after the mechanical interaction of blood with heparan
sulfate-depleted endothelium, erythrocytes also lose this
glycocalyx constituent. This observation led to the conclu-
sion that the vascular sodium buffer capacity of an individ-
ual could be derived from a blood sample. A test system
(salt blood test (SBT)) was developed based upon the
sodium-dependent erythrocyte zeta potential. Erythrocyte
sedimentation velocity was measured in isosmotic,
biopolymer-supplemented electrolyte solutions of different
sodium concentrations. Erythrocyte sodium sensitivity
(ESS), inversely related to erythrocyte sodium buffer capac-
ity, was expressed as the ratio of the erythrocyte sedi-
mentation velocities of 150 mM over 125 mM Na+
solutions (ESS = Na+150/Na
+
125). In 61 healthy individ-
uals (mean age, 23±0.5 years), ESS ranged between 2
and 8. The mean value was 4.3±0.19. The frequency
distribution shows two peaks, one at about 3 and another
one at about 5. To test whether ESS reflects changes of
the endothelial glycocalyx, a cultured endothelial mono-
layer was exposed for 3 hours to a rhythmically moving
blood layer (drag force experiment). When applying this
procedure, we found that ESS was reduced by about
21 % when the endothelium was pretreated for 4 days
with the glycocalyx protective agent WS 1442. In con-
clusion, the SBT could possibly serve as an in vitro test
system for the evaluation of erythrocyte/vascular salt
sensitivity allowing follow-up measurements in the pre-
vention and treatment of vascular dysfunctions.
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Introduction
At least one third of the world's population is supposed to be
sensitive to salt [32], i.e., arterial hypertension occurs in
response to the daily ingestion of large amounts of sodium,
a habit widely spread in our societies [19]. Sodium is bound,
osmotically inactive, to the negatively charged proteogly-
cans in the dermis [30] and endothelial glycocalyx (eGC)
[1]. Sodium overload damages the eGC [24], thus
diminishing endothelial sodium buffer capacity. Deteriora-
tion of the eGC allows sodium exiting the blood vessel
lumen more readily via endothelial sodium channels [17,
26]. As a consequence, sodium spends more time in the
extracellular space before being finally cleared by the kidneys
[16, 22]. This delayed sodium excretion leads in the long term
to sodium deposition in the body, thereby damaging various
tissues [12, 14]. Based on this concept, the salt provocation
test was developed which quantifies vascular sodium sensi-
tivity in vivo [21]. Vascular sodium sensitivity, inversely
related to endothelial sodium buffer capacity, characterizes
the quality of the endothelial glycocalyx. Recently, it has been
realized that the glycocalyx of erythrocytes (red blood cells
(RBC)) reflects some specific surface properties of endothelial
cells [20]. In more details, RBC allowing to physically
interacting (“drag force treatment”) with the endothelial sur-
face in vitro acquire characteristics of the endothelial surface
layer. For example, when the endothelial surface layer is
experimentally depleted of negative charges—heparan sulfate
shedding by the application of the enzyme heparinase—and
then RBC allowed to interact for some hours, the RBC
glycocalyx is found shed after such a drag force experiment
[20]. This observation led to the conclusion that the vascular
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salt sensitivity could be indirectly measured by evaluating the
erythrocyte salt sensitivity (ESS). A method (salt blood test
(SBT)) was developed based on the sodium sensitivity of the
RBC zeta potential [9, 10]. As a proof of principle, the
hawthorn-derived compound WS 1442 known to improve
endothelial function, in particular the endothelial glycocalyx
[2, 26], was applied in vitro to test whether the SBT “reports”
such changes.
Methods
Principle and procedure of the SBT
Experimental steps 1–3 are documented in Fig. 1a–c. In
detail, 2 ml of blood is drawn from volunteers by venous
puncture using heparinized monovettes (Sarstedt Company,
Sarstedt, Germany). Blood is transferred in 2-ml plastic
vials (Eppendorf AG, Hamburg, Germany) and centrifuged
at 1,800×g for 5 min. Plasma and buffy coat are removed,
and erythrocytes were washed two times in 30 ml of
HEPES-buffered (10 mM HEPES=2-(4-(2-hydroxyethyl)-
1-piperazinyl)-ethane sulfonic acid) sodium chloride
(150 mM NaCl) including 1 % bovine serum albumin
(PAA Clone, Coelbe, Germany). This amount of serum is
necessary for proper shielding of the glycocalyx. For a
single measurement, 80 μl of washed RBC is suspended in
120 μl NaCl solution (fixed hematocrit, 0.4) containing 3 %
dextran (Sigma 4486, MW 70,000 D). Dextran is adsorbed
to the RBC surface triggering RBC aggregation (Fig. 1d, e).
This phenomenon is called “macromolecular bridging,” in-
dicating that the adhesion forces between RBC overcome
the electrostatic repulsive forces [9, 10]. NaCl concentra-
tions were varied between 50 and 150 mM as appropriate.
Sucrose at various amounts was added for maintaining
constant osmolality. The test solutions containing varying
NaCl concentrations, varying sucrose concentrations, and a
fixed concentration of dextran (3 %) are called “Na+ cock-
tails” throughout the paper. Hematocrit capillary tubes
(Safecap P75-2000; length 75 mm; Scholz Company,
Neubiberg, Germany) were filled by capillary forces with
the respective RBC suspensions as appropriate. Hematocrit
capillary tubes, closed at the lower end, were put on stands
in an upright position (Fig. 2). RBC sedimentation rates
were measured at appropriate time intervals. The dimension-
less ESS values of the individual blood samples were cal-
culated as the ratio of the respective RBC sedimentation
velocities in 150 and 125 mM Na+ cocktail (ESS =
L150/L125). It should be mentioned that a single ESS mea-
surement needs only about 200 μl blood which can be
obtained from a puncture of the fingertip. The SBT was
performed at ambient temperature. pH values of the Na+
cocktails were around 7.4 (due to the endogenous buffering
power of hemoglobin at the fixed hematocrit of 0.4).
Drag force treatment
Endothelial monolayers (human Eahy629 cell line) were
cultured for 4 days on the bottom of 75-cm2 culture flasks
[4, 15, 18] in the absence (control) and presence of the
vasoprotective Crataegus extract WS 1442 (10 μg/ml) [2].
WS 1442 is known to improve glycocalyx function in vitro
[26]. After this period, the culture medium was replaced by
whole blood (2.5 ml per flask) taken from volunteers (hep-
arinized monovettes; Sarstedt Company, Sarstedt, Germa-
ny). The flasks, mounted on a shaker (4 shifts per min, 7°
angle), were placed in a cell culture incubator (37 °C, 5 %
CO2) and rocked for 3 h so that the RBC could mechanically
interact with the surface of the endothelial cell layer. This
procedure named drag force treatment was described in
detail recently [20].
Results
In contrast to the standard erythrocyte sedimentation rate
(ESR) which is performed in whole blood and strongly
dependent on any inflammation-relevant proteins in the
plasma phase [27], the sedimentation rate used for ESS
measurements is independent of any proteins, but strongly
dependent on the NaCl concentration of the electrolyte
solution in which the erythrocytes have been suspended. In
particular, sedimentation rate depends on the RBC zeta
potential [10] and, thus, on the RBC glycocalyx. Since
Na+ neutralizes the negative charges of the RBC surface,
sedimentation rate reflects the Na+ buffer capacity of the
RBC glycocalyx. As mentioned above, dextran is needed in
all solutions; otherwise, aggregation does not occur. In pilot
studies, we found out that the most suitable molecular mass
of the dextran is 70,000 D, and the most adequate concen-
tration is 3 %. This is in good agreement with a previous
study [10]. Figure 2 shows the time dependence of the RBC
sedimentation rate. Initial sedimentation rates are quite lin-
ear, but they saturate later on. This is due to the fact that a
hematocrit of 0.40 was used so that after long time periods
(hours), virtually all RBC, not only the large RBC aggre-
gates, concentrate in the lower part of the tube. Therefore,
the 60-min values were chosen for analysis. Figure 3 shows
the dependence of the erythrocyte sedimentation on NaCl
concentration. Ion strength, and in particular the cation Na+,
determines sedimentation velocity. The reason why the 125
and 150 mM Na+ concentrations have been chosen for the
SBT were as follows: The RBC glycocalyx is treated as a
Na+ buffer. At too low Na+ concentrations (below 100 mM),
the negative charges of the RBC glycocalyx are heavily
1460 Pflugers Arch - Eur J Physiol (2013) 465:1459–1466
undersaturated, making the test insensitive (i.e., the zeta
potential is at its maximum). At too high Na+ concentrations
(beyond 150 mM), the negative charges are completely
saturated again, making the test insensitive. Also, it was
tried to use NaCl concentrations close to the physiological
range. This strategy includes isosmotic conditions (appro-
priate addition of sucrose to the low Na+ solutions) and
“normal” osmolality (about 300 mOsm) of the electrolyte
solutions. Figure 4 displays two representative measure-
ments. From the respective supernatants, ESS could be
calculated. The ESS on the left side of Fig. 4 was 2.2,
indicating that RBC sedimentation rate was 2.2 times larger
in 150 mM Na+ than the sedimentation rate in 125 mM Na+.
The ESS on the right side of Fig. 4 was 5.8, indicating that
RBC sedimentation rate was 5.8 times larger in 150 mM
Na+ than that in 125 mM Na+. Thus, ESS of blood no. 2 was
more than twice as high as the ESS of blood no. 1. In a
series of control experiments, the heparan sulfate residues of
the RBC glycocalyx were enzymatically removed by
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Fig. 1 Theory and practice of the salt blood test. From venipuncture to measurement (a–c). Theory underlying slow and fast erythrocyte (RBC)
















After: 60 min        75 min        90 min         105 min        120 minFig. 2 Time dependence of the
erythrocyte sedimentation rate.
RBC were suspended in a
150 mM sodium cocktail (fixed
hematocrit=0.40; see
“Methods”)
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In six experiments, ESS increased only by about 13 % (from
2.6±0.12 to 3.0±0.14), indicating that not only heparan
sulfate residues but also other negatively charged (and
heparinase-insensitive) components of the glycocalyx con-
tribute to the sodium-dependent sedimentation rate.
Figure 5 displays ESS measured in 61 healthy volunteers
of similar age. The frequency distribution indicates two ESS
peaks, one at about 3 and another one at about 5. Figure 6
shows these data in more detail. Forty-six percent (28 out of
61) of the study participants exhibited an ESS of at least
20 % below average. Twenty-eight percent (17 out of 61) of
the study participants exhibited an ESS of at least 20 %
above average. Figure 7 shows that there is no significant
gender difference of the respective ESS. It is worth men-
tioning here that the SBT has been performed in all exper-
iments at a fixed hematocrit (0.40; see “Methods”). Taken
together, the data indicate that there is a wide range of ESS
(from 2 to 8) in the normal population. It should be men-
tioned that at least five individuals (red columns in Fig. 6)
were on low-salt diets (for no obvious reason, they indicated
this explicitly in a questionnaire). Remarkably, the ESS of
all five of them was found in the “weakly salt-sensitive”
group.
To test whether the RBC surface (i.e., the RBC
glycocalyx) suffers when blood is rhythmically dragged
across the surface of an endothelial monolayer and whether
the expected shedding of the RBC glycocalyx could be
prevented (and thereafter verified by the SBT), endothelial
monolayers were incubated for 4 days with and without
10 μg/ml WS 1442, a hawthorn extract rich in polyphenols
[26]. After this period of incubation, drag force treatment
was applied (see “Methods”). The blood overlaying the
monolayers was analyzed (performing the SBT) after a 3-h
period of drag force treatment. Figure 8 shows the results.
ESS analyzed from these blood samples was 5.8±0.48 (con-
trol; n=12, mean ± standard error of the mean (SEM)) and
4.5±0.31 (WS 1442; n=12, mean ± SEM). Taken together,
the erythrocyte glycocalyx is less shed (−21 %) during drag
force treatment by pretreating the endothelium in culture
with WS 1442. These data support previous findings, name-
ly, that (a) WS 1442 protects the endothelial glycocalyx, and
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Fig. 3 Dependence of the length of the RBC-free supernatant on time
and NaCl concentration. Osmolality is kept constant at 300 mOsm by
adding appropriate amounts of sucrose. The 60-min value is used for
evaluating the erythrocyte sodium sensitivity
L150/L125 =  2.2 = ESS                       L150/L125 =  5.8 = ESS 
Blood #1 
 






low Na+ buffer capacity = high ESS 
Fig. 4 ESS measurements
indicating weak erythrocyte
Na+ sensitivity (blood
no. 1) and strong erythrocyte
Na+ sensitivity (blood
no. 2). ESS erythrocyte sodium
sensitivity
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(b) the ESS reports surface properties of the endothelium
with which the blood has been interacting before.
Discussion
Arterial hypertension and related vascular diseases have
high mortality rates worldwide. One of the major risk factors
is high sodium intake [19]. Obviously, there is an imbalance
between sodium intake and renal sodium excretion. Salt
sensitivity, i.e., the development of hypertension in response
to salt, differs among people. The reasons for the different
salt sensitivities are largely unknown. It could be related to
the intrinsic ability of the kidneys to excrete sodium [7], to
the limited storage capacities of the skin and muscle [14] or
to a variable sodium buffer capacity of the vasculature [24].
There are reports that a single salty meal elevates plasma
sodium for a few millimoles per liter which has a
measureable impact on blood pressure [29] and endothelial
cell function [25]. Possibly, there is a sodium sensor in
vascular endothelium [23]. A candidate could be the epithe-
lial sodium channel (ENaC). This channel not only controls
renal sodium excretion but also regulates the function of
vascular endothelium [11]. Obviously, at least in vitro
1 2 3  4  5 6 7  8  9



















Mean age: 22.6 ± 0.49 years 
Fig. 5 Frequency distribution
of the erythrocyte sodium
sensitivity in a cohort of 61
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Mean age: 22.6 ± 0.49 years 
31 females/30 males 
    = low sodium diet 
Fig. 6 Erythrocyte sodium
sensitivity (triple
measurements) of the same
study participants as displayed
in Fig. 7. The overall mean
value is 4.3±0.19 (n=61). Five
study participants explicitly
indicated to be on a low-salt
diet (red columns)
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endothelial sodium sensitivity is linked to endothelial ENaC
activity and the function of the endothelial glycocalyx [15,
24]. According to this concept, the so-called salt provoca-
tion test (SPT) was developed [21]. The SPT is an in vivo
test which quantifies vascular salt sensitivity. In principle,
blood pressure is measured after an oral sodium load in the
presence and absence of a sodium channel blocker. The SPT
evaluates the sodium buffer capacity of the endothelial
glycocalyx and, hence, the vascular salt sensitivity of the
individual. Although the design of the SPT is quite straight-
forward, two separate sessions are necessary, each with
repetitive blood pressure measurements over 1 h, an oral
salt load, and the application of a sodium blocker. Therefore,
it appeared attractive to develop a blood-based in vitro test
system which should allow the evaluation of vascular sodi-
um sensitivity. As described recently by means of atomic
force microscopy imaging techniques, RBC “reflect” proper-
ties of the endothelial surface [20]. In detail, when heparan
sulfate residues are enzymatically removed from the endothe-
lial glycocalyx, then RBC—upon physical interaction—also
lose these key glycocalyx components. This observation,
namely, that the surface of RBC obviously “memorizes”
the surface of the endothelium, led us to conclude that
it should be sufficient to functionally test for the prop-
erties of the RBC and thus get insight into the proper-
ties of the respective endothelium.
61 subjects 
30 males/31 females 


























P = 0.33 (Mann−Whitney test)  
Fig. 7 Erythrocyte sodium
sensitivity (triple
measurements) of the same
study participants as displayed
in Figs. 5 and 6. Here, the data
(displayed as box plots) are split
into male and female groups,
respectively




























P = 0.015 (paired t test)  Drag-force experiment
12                              12
Fig. 8 Erythrocyte sodium
sensitivity measured in RBC
harvested from blood overlays
after drag force treatment.
Control no pretreatment.
WS 1442 4-day pretreatment of
the endothelium (in culture)
with 10 μg/ml of hawthorn
extract WS 1442. A number of
measurements are indicated
in columns. The inset shows
two culture flasks with
endothelial monolayers and
blood overlays, located on a
shaker, indicating that the blood
underwent drag force
treatment before the SBT was
performed
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The SBT is based on the sodium-dependent RBC
zeta potential [9, 10]. Its magnitude is directly related
to the negative surface charges. Besides sialic acids [5],
heparan sulfate residues [3, 13, 31] are supposed to
contribute to the RBC zeta potential. They preferentially
bind sodium [1]. ESR is used as a quantitative measure
for the sodium-dependent zeta potential [9, 10]. In con-
trast to standard ESR used as a nonspecific test for
inflammatory or tumorous processes in clinical medicine
[6], the SBT is performed in plasma-free electrolyte
solution. Besides various concentrations of NaCl, only
sucrose (for osmolality reasons) and dextran (triggering
aggregation) are present in the Na+ cocktails. Therefore,
the key variable in the RBC suspensions is Na+ which
preferentially binds to the heparan sulfate residues.
Two different Na+ cocktails are sufficient for performing
the SBT. The 125 mM Na+ cocktail sets the reference value
of the ESR. The 150 mM Na+ cocktail sets the upper limit.
The dimensionless ESS (Na+150/Na
+
125) is a measure for the
salt sensitivity of an individual. It would have the value “1”
when the increase of Na+ from 125 to 150 mM would not
change the zeta potential at all. This would indicate “no
sodium sensitivity,” a theoretical value that will never occur.
A value above 1 indicates “sodium sensitivity,” i.e., as larger
is this value as more sensitive to sodium is the individual's
vasculatory system (i.e., RBC and endothelium).
One of the aims of this study was to provide, as a first
step, a “reference value” of sodium sensitivity expressed as
ESS. Therefore, we performed the SBT in a cohort of 61
healthy young individuals. Although the number of study
participants is rather low and thus the interpretation of the
data is limited, there are two peaks in ESS. This could not
only be due to a genetic predisposition [28] but also due to
distinct differences in lifestyle [8]. Possibly, the left peak
includes individuals with a “weak” sensitivity to sodium,
while the right peak includes individuals with a “marked”
sensitivity to sodium (see Fig. 5). Gender differences cannot
explain these two peaks.
The SBT will gain a medical relevance only if the
concept, namely, that the sodium buffer capacity of the
endothelial glycocalyx (related to the inverse of ESS)
can be indeed evaluated, is proven, at least in an in
vitro experiment. This led us to perform “drag force”
experiments in combination with the vasoprotective
compound WS 1442. This Crataegus extract is known
to improve endothelial function [2] and specifically in-
teracts with the endothelial glycocalyx. At least in vitro,
WS 1442 has been shown to unfold (“swell”) the
glycocalyx and lowers endothelial sodium permeability
[26]. Indeed, ESS significantly decreased by 21 % when
the endothelium was pretreated for several days with
this compound. Taken together, we assume a mechanism
as follows:
Treatment of the endothelium with WS 1442 in vitro
swells the endothelial glycocalyx [26]. This improves elec-
trical surface negativity and, thus, endothelial sodium buffer
capacity [24]. During drag force treatment, erythrocytes
mechanically interact. By these means, the RBC surfaces
“acquire” properties of the endothelial surface, i.e., their
sodium-dependent zeta potentials rise. This results in a
decrease of ESS.
Although this is only a first step in the proof of this
concept, it opens some interesting perspectives. Sodium
sensitivity, at the level of the vascular system, is probably
not a “constant” parameter of an individual but is rather a
variable that can be (negatively or positively) influenced.
This view could make the SBT as a potentially valuable test
system in the control of medical measures undertaken to
improve vascular function.
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